ESAR has developed a questionnaire to seek expert views on a number of topics related to low-level viremia.
There were two areas identified that require discussion prior to the formulation of recommendations: additional diagnostic testing and clinical management.
The questionnaire is developed to achieve a consensus for the panel position paper that we are developing. All ESAR Board & Council members and other experts in the field were asked to fill out the questionnaire. During the Guidelines Meeting in Glasgow November 3rd Marije Hofstra presented the first results on the clinical management of the low level viremia questionnaire.
At this moment it is no longer possible to fill out the low level viremia questionnaire
ESAR low-level viremia guidance committee
Charles Boucher
Diane Descamps
Anna Maria Geretti
Richard Harrigan
Marije Hofstra
Linos Vandekerckhove
Annemarie Wensing
There were two areas identified that require discussion prior to the formulation of recommendations: additional diagnostic testing and clinical management.
The questionnaire is developed to achieve a consensus for the panel position paper that we are developing. All ESAR Board & Council members and other experts in the field were asked to fill out the questionnaire. During the Guidelines Meeting in Glasgow November 3rd Marije Hofstra presented the first results on the clinical management of the low level viremia questionnaire.
At this moment it is no longer possible to fill out the low level viremia questionnaire
ESAR low-level viremia guidance committee
Charles Boucher
Diane Descamps
Anna Maria Geretti
Richard Harrigan
Marije Hofstra
Linos Vandekerckhove
Annemarie Wensing